The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Interventions for valvular disease and heart failure

Edwards SAPIEN 3 implanted in a failing aortic bioprosthesis: first report

EuroIntervention 2016;11:e1321 published online e-edition February 2016. DOI: 10.4244/EIJV11I11A255

Groupe CardioVasculaire Interventionnel, Clinique Pasteur, Toulouse, France

An 87-year-old female was admitted for symptomatic failure of a 23 mm Carpentier-Edwards PERIMOUNT aortic bioprosthesis (Edwards Lifesciences, Irvine, CA, USA) implanted 17 years previously. Both severe central regurgitation and severe stenosis (mean gradient 60 mmHg) were identified. Due to a significant perioperative risk of redo surgery (EuroSCORE 46.5%, STS 7.3%), the Heart Team decided on transfemoral valve-in-valve (ViV) implantation. A 23 mm Edwards SAPIEN 3 (S3) device (Edwards Lifesciences) was chosen, based on a measured inner diameter of 20.5 mm by multislice computed tomography (MSCT) and of 21 mm as reported by the manufacturer. The ViV procedure was performed under conscious sedation and fluoroscopy guidance. The ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Tools and Techniques – Statistical. Estimating cumulative incidences in the presence of right-censoring and competing risks: an introduction with illustrations from the COACH study